tiprankstipranks
Perspective Therapeutics (CATX)
NYSE MKT:CATX
Holding CATX?
Track your performance easily

Perspective Therapeutics (CATX) Financial Statements

1,134 Followers

Perspective Therapeutics Financial Overview

Perspective Therapeutics's market cap is currently ―. The company's EPS TTM is $-0.928; its P/E ratio is -3.23; Perspective Therapeutics is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.26. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Jun 23Mar 23Dec 22
Income Statement-
Total Revenue$ 369.00K$ 526.00K$ 1.50M$ 2.06M$ 1.83M
Gross Profit$ 369.00K$ 526.00K$ 248.00K$ 487.00K$ 403.00K
EBIT$ -15.12M$ -11.25M$ -10.49M$ -10.85M$ -3.20M
EBITDA$ -14.45M$ -10.68M$ -10.23M$ -10.66M$ -3.20M
Net Income Common Stockholders$ -15.12M$ -11.70M$ -11.11M$ -371.00K$ -2.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 267.85M$ 292.87M$ 28.32M$ 36.45M$ 43.76M
Total Assets$ 391.15M$ 385.92M$ 120.14M$ 127.64M$ 58.28M
Total Debt$ 4.27M$ 3.88M$ 2.58M$ 2.12M$ 392.00K
Net Debt$ -263.58M$ -288.99M$ -25.74M$ -34.34M$ -43.37M
Total Liabilities$ 62.68M$ 44.92M$ 11.49M$ 9.62M$ 3.27M
Stockholders Equity$ 328.47M$ 341.00M$ 108.65M$ 118.03M$ 55.01M
Cash Flow-
Free Cash Flow$ -26.37M$ -9.92M$ -8.63M$ -9.92M-
Operating Cash Flow$ 3.37M$ -8.90M$ -8.07M$ -9.72M-
Investing Cash Flow$ -29.74M$ -3.29M$ -573.00K$ 25.26M-
Financing Cash Flow$ 628.00K$ 122.08M$ 512.00K$ -80.00K-
Currency in USD

Perspective Therapeutics Earnings and Revenue History

Perspective Therapeutics Debt to Assets

Perspective Therapeutics Cash Flow

Perspective Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis